187 related articles for article (PubMed ID: 25827817)
61. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
[TBL] [Abstract][Full Text] [Related]
62. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
63. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers.
Ntinas A; Zambas N; Al Mogrambi S; Petras P; Chalvatzoulis E; Frangandreas G; Tsantilas D; Spiridis C; Gerasimidis T
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s190-2. PubMed ID: 15655619
[TBL] [Abstract][Full Text] [Related]
64. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
65. Is Liver Ultrasound Useful as Part of the Surveillance Strategy following Potentially Curative Colorectal Cancer Resection?
Schneider J; Koullouros M; Mackay C; Ramsay G; Parnaby C; Stevenson L
Dig Dis; 2019; 37(3):234-238. PubMed ID: 30466102
[TBL] [Abstract][Full Text] [Related]
66. Yield of routine imaging after curative colorectal cancer treatment.
Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
[TBL] [Abstract][Full Text] [Related]
67. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of follow-up after surgical treatment of colorectal liver metastases.
Langenhoff BS; Krabbe PF; Ruers TJ
Eur J Surg Oncol; 2009 Feb; 35(2):180-6. PubMed ID: 18691847
[TBL] [Abstract][Full Text] [Related]
69. Intensive Follow-Up After Curative Surgery for Colorectal Cancer.
Rodrigues RV; Pereira da Silva J; Rosa I; Santos I; Pereira N; Soares C; Pereira AD
Acta Med Port; 2017 Sep; 30(9):633-641. PubMed ID: 29025530
[TBL] [Abstract][Full Text] [Related]
70. Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Clin Transl Oncol; 2018 Feb; 20(2):176-192. PubMed ID: 28710725
[TBL] [Abstract][Full Text] [Related]
71. Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer.
Bergamaschi R; Arnaud JP
Ann Surg Oncol; 1996 Sep; 3(5):464-9. PubMed ID: 8876888
[TBL] [Abstract][Full Text] [Related]
72. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
73. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
[TBL] [Abstract][Full Text] [Related]
74. Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.
Fora A; Patta A; Attwood K; Wilding G; Fakih M
Oncology; 2012; 82(1):41-7. PubMed ID: 22286543
[TBL] [Abstract][Full Text] [Related]
75. [Tumor surveillance after resection of colorectal cancer].
Vorburger SA; Gloor B; Candinas D
Ther Umsch; 2008 Jun; 65(6):329-34. PubMed ID: 18622956
[TBL] [Abstract][Full Text] [Related]
76. Repeat pulmonary resection for recurrent lung metastases from colorectal cancer: an analysis of prognostic factors.
Hachimaru A; Maeda R; Suda T; Takagi Y
Interact Cardiovasc Thorac Surg; 2016 Jun; 22(6):826-30. PubMed ID: 26920721
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F
Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
[TBL] [Abstract][Full Text] [Related]
78. The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
Shinkins B; Nicholson BD; Primrose J; Perera R; James T; Pugh S; Mant D
PLoS One; 2017; 12(3):e0171810. PubMed ID: 28282381
[TBL] [Abstract][Full Text] [Related]
79. When does curatively treated colorectal cancer recur? An Australian perspective.
Reece MM; Chapuis PH; Keshava A; Stewart P; Suen M; Rickard MJFX
ANZ J Surg; 2018 Nov; 88(11):1163-1167. PubMed ID: 30277301
[TBL] [Abstract][Full Text] [Related]
80. Follow-up of colorectal cancer: a meta-analysis.
Rosen M; Chan L; Beart RW; Vukasin P; Anthone G
Dis Colon Rectum; 1998 Sep; 41(9):1116-26. PubMed ID: 9749495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
